Month: March 2023

– Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital ichthyosis, ARCI and XLRI – – Timber has enrolled 50% of patients for pivotal TMB-001 Phase 3 ASCEND clinical trial – WARREN, NJ, March 31, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the fourth quarter and year ended December 31, 2022. John Koconis, Chairman and Chief Executive Officer of Timber, commented, “Timber had an exciting year in 2022 and achieved...

WOOD DALE, Ill., March 31, 2023 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (the “Company” or “PSI”) (OTC Pink: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced fourth quarter and full year 2022 financial results. Fourth Quarter 2022 Results Sales for the fourth quarter of 2022 were $137.0 million, an increase of $10.0 million, or 8%, versus the comparable period last year. The improvement in sales is comprised of increases of approximately $19.5 million and $10.0 million in the industrial and power systems end markets, respectively, partially offset by a decrease of $19.5 million in the transportation end market. The increased sales within the industrial end market primarily reflect increased demand for products used in the material handling/forklift...

Midland, Texas, March 31, 2023 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (NYSE:NGS) (the “Company” or “NGS”), a leading provider of gas compression equipment and services to the energy industry, announces it’s upcoming Earnings Call and its financial results for the three months and full year ended December 31, 2022. The Earnings call will be hosted on Monday, April 3, 2023 at 9:00 a.m. (CST), 10:00 a.m. (EST). To  participate  in  the  call,  participants  should  access  the  webcast on www.ngsgi.com under the Investor Relations section. To connect telephonically, call (800) 715-9871 using conference ID 5410343 approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company’s website. Financial...

VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Highlights ·       Generated revenue of $1.45 million in the fourth quarter of 2022 (91% growth against the fourth quarter of 2021), and $3.8 million for the full year 2022 (49% growth against fiscal 2021). ·       On March 13, 2023, following the conclusion of oral arguments on March 9, 2023, the U.S. Court of Appeals for the Federal Circuit issued a summary order affirming the judgment of the District Court for the Southern District of New York (the “District Court”).  On February 1, 2022, the District Court had dismissed the class action litigation against the Company and certain of its...

Achieved record quarterly revenue of $12.1 million in the fourth quarter $60.3 million net proceeds from our Nasdaq listing in February 2023 expected to provide runway to expand sales & marketing, develop new products, and execute operations for future growth Announced early access to new OBSKUR™ platform, providing user-friendly tools for livestreaming influencers to deliver interactive experiencesHENDERSON, Nev., March 31, 2023 (GLOBE NEWSWIRE) — Movella Holdings Inc. (NASDAQ: MVLA) (“Movella”), a leading full-stack provider of sensors, software, and analytics that enable the digitization of movement, today reported its results for the fourth quarter and twelve months ended December 31, 2022. “2022 was an exciting and transformative year for Movella as we positioned ourselves to become a publicly traded company...

Record Net Revenue up 34% with Strong Subscription-Based Revenue Growth LAS VEGAS, March 31, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading developer and distributor of plant-based nutraceutical products for heart and brain health, reported results for the year ended December 31, 2022. All comparisons are to the year-ago period unless otherwise noted. 2022 Financial HighlightsNet revenue totaled a record $2.3 million, up 34%, due to product line and distribution channel expansion. Gross profit totaled $1.4 million, up 97%, driven by revenue growth and higher gross margins. Gross margin was 60.9% versus 41.5% in 2021. Normalizing for certain inventory utilization, gross margin was 65.2% in 2022 and 66.8% in 2021. Operating expenses decreased 12% to $2.3 million, which included $457,000 in non-cash expense...

DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK), a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided strategic, financial, and operational updates for the year ended December 31, 2022. Jeff Wolf, Chief Executive Officer of NightHawk, commented, “We are making progress on our transition towards biodefense and biomanufacturing through our Elusys and Scorpion subsidiaries as we wind down our HS-110 and PTX-35 oncology programs. Pursuant to this, we are investing in our biomanufacturing technologies and capabilities, including our San Antonio and Manhattan, Kansas biologics manufacturing facilities, which we believe will position us well in the future. The manufacturing capabilities associated with these...

The Company continues its exploration process to target strategic and financing alternatives aimed at accelerating commercialization of the Pure-Vu System and maximizing stockholder value The Company is actively supporting its existing installed customer base and pipeline opportunities in contracted health systems   The Company is advancing its development of Pure-Vu EVS Gastro, designed for Upper GI bleeding procedures, and expects submission to FDA by the end of 2023FORT LAUDERDALE, Fla., March 31, 2023 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, today reported its financial results...

16% Revenue Growth for Full Year 2022; Ended the Year with Record Backlog of $27.7 Million CHANDLER, Ariz., March 31, 2023 (GLOBE NEWSWIRE) — VirTra, Inc. (Nasdaq: VTSI) (“VirTra”), a global provider of judgmental use of force training simulators, firearms training simulators for the law enforcement and military markets, reported results for the fourth quarter and full year ended December 31, 2022. The financial statements are available on VirTra’s website and here. Fourth Quarter 2022 and Full Year 2022 Highlights:Bookings of $6.4 million in the fourth quarter of 2022 and $33.0 million for 2022. Record backlog at December 31, 2022 of $27.7 million, 20% higher than prior year comparable period. Launched operations at a new facility in Orlando, Florida to support strategic growth in military end-market. Maintained a strong balance...